These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 3784036

  • 1. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N, Kumagai T, Kameko M, Kanai M.
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The significance of immuno-biologic parameters during and in the prognosis of patients with systemic lupus erythematosus].
    Ljaljević M, Ljaljević J, Zlatković Lj, Latković J.
    Glas Srp Akad Nauka Med; 1982 Aug; (35):111-20. PubMed ID: 7182242
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antinuclear factor, phenomena of the LE cells and complement in systemic erythematosus].
    Okuda M.
    Nihon Rinsho; 1968 Dec; 26(12):3438-48. PubMed ID: 4181083
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N, Haustein UF, Barthelmes H.
    Z Arztl Fortbild (Jena); 1971 Jun 15; 65(12):581-5. PubMed ID: 4939579
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Immunopathologic reactions in systemic lupus erythematosus and rheumatoid arthritis].
    Tarasenko RV.
    Vrach Delo; 1974 Feb 15; (2):24-7. PubMed ID: 4468615
    [No Abstract] [Full Text] [Related]

  • 11. Clinical features of systemic lupus erythematosus patients with antihistone antibodies.
    Fritzler M, Ryan P, Kinsella TD.
    J Rheumatol; 1982 Feb 15; 9(1):46-51. PubMed ID: 7086779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH, Oon CJ, Yo SL, Lau YK.
    Singapore Med J; 1978 Sep 15; 19(3):120-4. PubMed ID: 751195
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Significance of selected immunological parameters in the diagnosis and follow-up of systemic lupus erythematosus].
    Wollina U, Knopf B, Koch HJ.
    Rev Med Chir Soc Med Nat Iasi; 1984 Sep 15; 88(4):697-700. PubMed ID: 6537639
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS.
    Vestn Dermatol Venerol; 1980 Nov 15; (11):17-22. PubMed ID: 7003977
    [No Abstract] [Full Text] [Related]

  • 18. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I, Moravenik M, Diumenjo MS, Vannucci J.
    Rev Clin Esp; 1977 Dec 15; 147(5):495-8. PubMed ID: 605255
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical importance of investigations of completed and incompleted phagocytosis and the level of serum complement as indicators of nonspecific immunological reactivity of patients with systemic lupus erythematosus].
    Ivanova AV, Selivanova IA, Poroshina NS, Gagarina LN.
    Vopr Revm; 1973 Dec 15; 13(2):51-2. PubMed ID: 4772875
    [No Abstract] [Full Text] [Related]

  • 20. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 15; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.